Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Design Example: Forces in Sluice Gate01:11

Design Example: Forces in Sluice Gate

3.0K
In hydraulic engineering, sluice gates are essential for managing water flow through channels, reservoirs, and irrigation systems. Sluice gates, acting as vertical barriers, regulate water by adjusting the gate's opening height, which changes the velocity and pressure of water flowing beneath the gate. Understanding the forces involved is crucial to designing sluice gates that can withstand dynamic pressure differences, especially when the gate is closed or partially open.
Key variables in...
3.0K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.8K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.8K
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.0K
Trial and Error and Algorithm01:12

Trial and Error and Algorithm

424
A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
424
Clinical Trials01:16

Clinical Trials

10.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.8K
Group Design02:01

Group Design

10.6K
The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between...
10.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction: Interventions against disability in frail older adults: Lessons learned from clinical trials.

The journal of nutrition, health & aging·2026
Same author

Corrigendum to "Current and investigational medications for the treatment of sarcopenia" [Metabolism 2023;149:155597].

Metabolism: clinical and experimental·2026
Same author

Challenges and opportunities for novel combination therapies in Alzheimer's disease: a report from the EU/US CTAD Task Force.

The journal of prevention of Alzheimer's disease·2025
Same author

Exercise interventions to improve physical frailty and physical frailty components in older adults with hypertension: A systematic review.

Ageing research reviews·2025
Same author

Editorial: ICOPE Healthy Longevity Integrative Preventive Care, Alzheimer's Disease Prevention and Early Diagnosis.

The journal of prevention of Alzheimer's disease·2024
Same author

Clinical Meaningfulness in Alzheimer's Disease Clinical Trials. A Report from the EU-US CTAD Task Force.

The journal of prevention of Alzheimer's disease·2024
Same journal

From health literacy to capacity preservation: advancing the next step in midlife frailty prevention.

The Journal of frailty & aging·2026
Same journal

An OLD DOG teaching us new tricks in ageing biology.

The Journal of frailty & aging·2026
Same journal

"This has no flavor": balancing nutrition, taste, and salt restriction in geriatric care units.

The Journal of frailty & aging·2026
Same journal

Screening of intrinsic capacity impairment in community-dwelling older adults in Cameroon: A national cross-sectional study.

The Journal of frailty & aging·2026
Same journal

Comparing two methods to quantify physical resilience.

The Journal of frailty & aging·2026
Same journal

Phenotypes of frailty and their mortality and disability implications.

The Journal of frailty & aging·2026
See all related articles

Related Experiment Video

Updated: Feb 6, 2026

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
05:53

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty

Published on: July 24, 2013

17.1K

Designing Drug Trials for Frailty: ICFSR Task Force 2018.

M Pahor1, S B Kritchevsky, D L Waters

  • 1Marco Pahor, University of Florida Institute on Aging, Gainesville, FL, USA, mpahor@ufl.edu.

The Journal of Frailty & Aging
|August 11, 2018
PubMed
Summary
This summary is machine-generated.

Frailty interventions are crucial for older adults. While lifestyle changes are ideal, drug treatments are needed for some, but development faces challenges.

Keywords:
Sarcopeniaclinical trialsfrailtygait speedshort physical performance battery

More Related Videos

Transferring Cognitive Tasks Between Brain Imaging Modalities: Implications for Task Design and Results Interpretation in fMRI Studies
10:09

Transferring Cognitive Tasks Between Brain Imaging Modalities: Implications for Task Design and Results Interpretation in fMRI Studies

Published on: September 22, 2014

13.6K
A Within-Subject Experimental Design using an Object Location Task in Rats
09:28

A Within-Subject Experimental Design using an Object Location Task in Rats

Published on: May 6, 2021

5.2K

Related Experiment Videos

Last Updated: Feb 6, 2026

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
05:53

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty

Published on: July 24, 2013

17.1K
Transferring Cognitive Tasks Between Brain Imaging Modalities: Implications for Task Design and Results Interpretation in fMRI Studies
10:09

Transferring Cognitive Tasks Between Brain Imaging Modalities: Implications for Task Design and Results Interpretation in fMRI Studies

Published on: September 22, 2014

13.6K
A Within-Subject Experimental Design using an Object Location Task in Rats
09:28

A Within-Subject Experimental Design using an Object Location Task in Rats

Published on: May 6, 2021

5.2K

Area of Science:

  • Gerontology
  • Pharmacology
  • Public Health

Background:

  • Frailty is a key target for reducing disability and dependence in older adults.
  • Lifestyle interventions are optimal for prevention, but pharmacological treatments are necessary for individuals meeting frailty criteria or with complicating comorbidities.
  • Drug development for frailty is hindered by inconsistent definitions, diagnostic tools, outcome measures, and lack of validated biomarkers.

Purpose of the Study:

  • To review the status of frailty treatments under development.
  • To discuss strategies for advancing drug development for frailty.
  • To identify potential regulatory pathways for frailty interventions.

Main Methods:

  • The International Conference on Frailty and Sarcopenia Research Task Force convened to discuss the state of frailty treatment research.
  • The task force considered existing and emerging pharmacological approaches.
  • Discussions focused on regulatory strategies and biomarker development.

Main Results:

  • The development of drug treatments for frailty faces significant barriers, including definitional variability and lack of validated biomarkers.
  • Adjuvant treatments or trials targeting specific functional outcomes, such as gait speed, may offer a more viable regulatory pathway currently.
  • Ongoing studies are expected to provide crucial insights for future drug development.

Conclusions:

  • Addressing frailty requires a multi-faceted approach, including both lifestyle and pharmacological interventions.
  • Overcoming current barriers is essential for advancing the development of effective drug treatments for frailty.
  • Future research holds promise for improving the treatment landscape for frailty syndrome.